Teva Reports Growth in Fourth Quarter and Full Year 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
2023 revenues outlook revised to $15.1 - $15.5 billion from $15.0 - $15.4 billion
Global revenues of $3.9 billion, reflect an increase of 7% from the third quarter of 2022
Increased revenues.
08.11.2023 - Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reported results for the quarter ended September 30, 2023. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231108857866/en/ .
Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended March 31, 2023.
This press release features multimedia. View the full release here:. | May 10, 2023
Teva Reports Third Quarter 2022 Financial Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.